Calquence 100 MG tablet 60S
Ended Awarded
- Contract number
- SPE2DB25FJE93
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $16,781
Award facts
- Contract value 100% obligated
- $16,781.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order contract to AmerisourceBergen Drug Corp for the supply of Calquence 100 mg tablets (60-count units) with a ceiling value of $16,781.31. This firm fixed-price delivery order, awarded on August 1, 2025, with an ultimate completion date of August 22, 2025, represents a non-competitive set-aside contract. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in the same city. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare systems.
The Calquence supply aligns with AmerisourceBergen's extensive portfolio of pharmaceutical deliveries through the DLA Medical Supply Chain, which encompasses specialty medications, brand-name and generic drugs, and other medical commodities across multiple therapeutic domains. As a critical vendor for federal medical procurement supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, AmerisourceBergen has consistently demonstrated its capability to meet federal procurement requirements. The company's SPE2DX prime IDV enables flexible fulfillment of pharmaceutical needs across military healthcare programs worldwide, positioning the company as a key supplier for the DLA's ongoing medical supply requirements.
Quick answers
Who was awarded contract SPE2DB25FJE93?
SPE2DB25FJE93 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 1, 2025.
How much is contract SPE2DB25FJE93 worth?
The government has obligated $16,781 on SPE2DB25FJE93.
Is contract SPE2DB25FJE93 an order under another contract?
Yes. SPE2DB25FJE93 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJE93 competed?
The extent of competition for SPE2DB25FJE93 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award